Fallopian Tube Cancer Clinical Trials

A listing of Fallopian Tube Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study evaluating GEN-1 for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Mobile Alabama 36604

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Arizona

Arizona Oncology Associates
Phoenix Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Arizona Oncology Associates
Tucson Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

View More ▼

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

California

Sutter West Bay
San Francisco California

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

View More ▼

Irvine California 92618

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

San Francisco California 94115

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Florida

SCRI Florida Cancer Specialists
West Palm Beach Florida

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

View More ▼

Miami Florida 33136

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Orlando Florida 32804

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Peritoneal Carcinomatosis or Fallopian Tube Cancer

Tampa Florida 33612

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

West Palm Beach Florida 33401

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Georgia

Northside Hospital
Atlanta Georgia

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Memorial University Medical Center
Savannah Georgia 31404

GOG 0273: Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer

View More ▼

Augusta Georgia 30912

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Illinois

University of Chicago
Chicago Illinois

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Northwestern University
Evanston Illinois

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

View More ▼

Chicago Illinois

A clinical research study of COTI2

Indiana

IU Melvine and Bren Cancer Center
Indianapolis Indiana

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

St. Vincent Hospital
Indianapolis Indiana

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Kentucky

Lexington Kentucky 40536

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Louisiana

Women’s Cancer Center
Covington Louisiana

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Maine

Scarborough Maine 04074

A clinical research study of Gemcitabine and pazopanib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Maryland

Baltimore Maryland 21287

A clinical research study of Gemcitabine and pazopanib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Massachusetts

Lahey Clinic
Burlington Massachusetts

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

View More ▼

UPDATED

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of Paclitaxel, Ricolinostat and Bevacizumab to evaluate Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Carcinoma

UPDATED

Boston Massachusetts 02115

Patients are needed to participate in a clinical research study of Paclitaxel, Ricolinostat and Bevacizumab to evaluate Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Carcinoma

Boston Massachusetts 02114

A clinical research study of IMGN853, Bevacizumab, Carboplatin and Doxorubicin for the treatment of Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer or Endometrial Cancer

Boston Massachusetts 02215

A clinical research study of IMGN853, Bevacizumab, Carboplatin and Doxorubicin for the treatment of Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer or Endometrial Cancer

Boston Massachusetts 02114

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Michigan

Detroit Michigan 48202

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Detroit Michigan 48201

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Missouri

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study evaluating GEN-1 for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

St. Louis Missouri 63110

Study Of Intraperitoneal EGEN-001 Administered In Combination With Pegylated Liposomal-Doxorubicin In Patients With Recurrent Or Persistent Epithelial Ovarian, Fallopian Tube Or Peritoneal Cancer

Montana

Billings Montana 59101

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Nebraska

Omaha Nebraska 68114

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

New Hampshire

Lebanon New Hampshire 03756

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

New Jersey

Basking Ridge New Jersey 07920

Patients are needed to participate in a clinical research study of Paclitaxel, Bevacizumab, Cisplatin and Olaparib to evaluate Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

New Mexico

Albuquerque New Mexico 87106

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

New York

Biomedical Research Alliance of New York
Lake Success New York 11042

Advanced Relapsed Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer

North Shore Long Island Jewish
New Hyde Park New York

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

View More ▼

Commack New York 11725

Patients are needed to participate in a clinical research study of Paclitaxel, Bevacizumab, Cisplatin and Olaparib to evaluate Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

New York New York 10065

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

New York New York 10065

Patients are needed to participate in a clinical research study of Paclitaxel, Bevacizumab, Cisplatin and Olaparib to evaluate Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

Rockville Centre New York 11570

Patients are needed to participate in a clinical research study of Paclitaxel, Bevacizumab, Cisplatin and Olaparib to evaluate Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

Sleepy Hollow New York 10591

Patients are needed to participate in a clinical research study of Paclitaxel, Bevacizumab, Cisplatin and Olaparib to evaluate Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

West Harrison New York 10604

Patients are needed to participate in a clinical research study of Paclitaxel, Bevacizumab, Cisplatin and Olaparib to evaluate Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer